Federal News
BARDA Awards $31.7M to Spectral AI in Texas
March 20, 2026
BARDA has awarded Spectral AI, Inc. an additional $31.7 million in non-dilutive funding under a contract valued up to $150 million to advance the DeepView AI-driven burn wound imaging system. This funding supports enhancements such as total body surface area mapping and expanded capabilities for burn mass casualty incidents. Spectral AI is contributing $9.7 million toward development costs and is pursuing FDA market authorization for the technology. The contract was awarded on March 18, 2026, and represents a significant investment in AI-enabled medical imaging to improve burn care outcomes.
- Why this matters: Procurement professionals should note the substantial federal investment in AI-driven medical technologies through BARDA, signaling growing opportunities in advanced healthcare imaging solutions.
- The contract emphasizes collaboration between federal agencies (BARDA, DHHS, ASPR) and private sector innovators to address public health preparedness.
- Contractors specializing in AI, medical imaging, and burn care technologies may find increased demand and funding opportunities in this niche.
- Organizations should consider the regulatory pathway with FDA authorization as a critical milestone impacting commercialization and procurement timelines.
Agencies
Biomedical Advanced Research and Development Authority, U.S. Food and Drug Administration, Department of Health and Human Services, Administration for Strategic Preparedness and Response
Vendors
Spectral AI, Inc.
Contracts
Up to $150.0 million
Locations
Sources
- Spectral AI gets $31.7M BARDA burn-care funding | MDAI SEC Filing - Form 8-K · Stock Titan · Mar 20